2. Introduction
• Extracted from the poppy plant
• Modulate the release of neurotransmitters
Watson WA, Litovitz TL, Rodgers GC Jr, et al. 2004 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 2005; 23:589.
Substance Abuse and Mental Health Services Administration. Results from the 2004 National Survey on Drug Use and Health: National Findings Office of Applied Studies, NSDUH Series H-28,
DHHS Publication No. SMA 05-4062, Rockville, MD 2005.
Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Drug Abuse WarningNetwork, 2004: National Estimates of Drug-Related Emergency Department Visits.
DAWN Series D-28, DHHS Publication No. (SMA) 06-4143, Rockville, MD 2006.
QuickStats: Number of Deaths From Poisoning,* Drug Poisoning,† and Drug Poisoning Involving Opioid Analgesics§ — United States, 1999–2010
ww.cdc.gov/mmwr/preview/mmwrhtml/mm6212a7.htm? s_cid=mm6212a7_e (Accessed on April 08, 2013).
Bonci A, Bernardi G, Grillner P, Mercuri NB. The dopamine-containing neuron: maestro or simple musician in the orchestra of addiction? Trends Pharmacol Sci 2003; 24:172.
3. Clinical Effects
• The analgesic effects of opioids result from inhibition of nociceptive
information at multiple points of its transmission from the
peripheral nerve to the spinal cord to the brain.
• Euphoria results from increased dopamine released in the
mesolimbic system
• Anxiolysis results from effects on noradrenergic neurons in the locus
ceruleus
Bonci A, Bernardi G, Grillner P, Mercuri NB. The dopamine-containing neuron: maestro or simple musician in the orchestra of addiction? Trends Pharmacol Sci 2003; 24:172.
Aghajanian GK, Wang YY. Common alpha 2- and opiate effector mechanisms in the locus coeruleus: intracellular studies in brain slices. Neuropharmacology 1987; 26:793.
4. Pharmacokinetics
• Elimination: renal
• Metabolism: hepatic
• The most clinically important pharmacokinetic difference is a wide
variation in serum half-life
Davies G, Kingswood C, Street M. Pharmacokinetics of opioids in renal dysfunction. Clin Pharmacokinet 1996; 31:410.
5. Pathophysiology
• Opioids increase activity at one or more G-protein–coupled
transmembrane molecules, known as the mu, delta, and kappa opioid
receptors
• The receptors are widely distributed throughout the human body
• The mu opioid receptor is responsible for the preponderance of
clinical effects caused by opioids
• Mu opioid receptors desensitization tolerance
• 60-200 mg morphine usually can induce fatal overdose
Waldhoer M, Bartlett SE, Whistler JL. Opioid receptors. Annu Rev Biochem. 2004;73:953–90
Stein C. The control of pain in peripheral tissue by opioids. N Engl J Med. 1995;332:1685–90
Whistler JL. Examining the role of mu opioid receptor endocytosis in the beneficial and side-effects of prolonged opioid use: from a symposium on new concepts in mu-opioid pharmacology. Drug Alcohol Depend. 2012;121:189–204.
6. Clinical Features
• Altered mental status ranging from mild euphoria or lethargy to coma
• Miotic pupils
• Decreased bowel sounds
• Low to normal heart rate and blood pressure
• Hypoventilation
Darke S, Zador D. Fatal heroin 'overdose': a review. Addiction 1996; 91:1765.
7. Physical Examination
Stolbach A, Hoffman RS. Acute opioid intoxication in adults. UpToDate, Waltham, MA.(Accessed on September 24, 2014.). 2015.
8. Treatment
• Ensure adequate ventilation
• Supplemental oxygen
• Naloxone (0.4 mg IV), followed by a rapid escalation to higher doses
(2 mg) if no response is observed within 2–3 min
Stolbach A, Hoffman RS. Acute opioid intoxication in adults. UpToDate, Waltham, MA.(Accessed on September 24, 2014.). 2015.
Morgan J, Jones AL. The role of naloxone in the opioid crisis. Toxicology Communications. 2018 Jan 1;2(1):15-8.
9. Prosser JM, Jones BE, Nelson L. Complications of oral exposure to fentanyl transdermal delivery system patches. J Med Toxicol. 2010;6:443–7.
Schumann H, Erickson T, Thompson TM, Zautcke JL, Denton JS. Fentanyl epidemic in Chicago, Illinois and surrounding Cook County. Clin Toxicol (Phila) 2008;46:501–6.
10. Clarke SF, Dargan PI, Jones AL. Naloxone in opioid poisoning: walking the tightrope. Emerg Med J.2005;22:612–6.
Hendra TJ, Gerrish SP, Forrest AR. Fatal methadone overdose. BMJ. 1996;313:481–2.
11. Summary
• Opioid analgesic overdose is a life-threatening condition
• Naloxone may have limited effectiveness in patients with poisoning
from long-acting agents.
• The unpredictable clinical course of intoxication demands empirical
management of this potentially lethal condition.